Table 5: Comparisons of thyroid hormones in patients before and after or ATD* treatments in the first investigation.

Before treatments
treatment (90 cases)ATD* treatment (90 cases) value ( value)**

FT3* (pmol/L)24.056 ± 5.32124.964 ± 4.6851.215 (0.226)
FT4* (pmol/L)117.633 ± 29.225117.225 ± 28.322−0.095 (0.924)
TSH* (IU/mL)0.007 ± 0.0110.009 ± 0.0140.757 (0.450)

Three months after treatments
treatment (90 cases)ATD* treatment (90 cases) value ( value)**

FT3* (pmol/L)5.837 ± 2.8307.252 ± 4.3302.595 (0.010)
FT4* (pmol/L)19.378 ± 8.29223.722 ± 13.1202.655 (0.009)
TSH* (IU/mL)6.427 ± 9.7025.539 ± 9.237−0.629 (0.530)

ATD: antithyroid drugs, FT3: free triiodothyronine, FT4: free thyroxine, and TSH: thyroid stimulating hormone; **analyzed by independent samples -test.